[1]
“A Rare Transition from Pemphigus Vulgaris to Pemphigus Foliaceus Following Rituximab Therapy Confirmed by Antidesmoglein ELISA ”, J of Skin, vol. 1, no. 1, pp. 37–40, Jun. 2017, doi: 10.25251/skin.1.1.6.